|0.066||-0.014 / -17.50%|
As of 12:41pm ET
|0.065||-0.001 / -1.52%|
The 1 analysts offering 12-month price forecasts for Immune Therapeutics Inc have a median target of 20.00, with a high estimate of 20.00 and a low estimate of 20.00. The median estimate represents a +30,203.03% increase from the last price of 0.07.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.